EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Integrated Eating Aversion Treatment Manual-Parent Version

Not Applicable

Completed

Conditions: Feeding and Eating Disorders of Childhood

Interventions: Behavioral: iEAT Manual Intervention
Behavioral: Control group

First Posted Date: 2016-03-29

Last Posted Date: 2017-10-16

Lead Sponsor: Emory University

Target Recruit Count: 17

Registration Number: NCT02721901

Locations: 🇺🇸
Marcus Autism Center, Atlanta, Georgia, United States

Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Autism MEAL Plan
Behavioral: Parent Education

First Posted Date: 2016-03-18

Last Posted Date: 2018-12-19

Lead Sponsor: Emory University

Target Recruit Count: 38

Registration Number: NCT02712281

Locations: 🇺🇸
Marcus Autism Center, Atlanta, Georgia, United States

Healing Hearts and Mending Minds in Older Adults Living With HIV

Not Applicable

Completed

Conditions: HIV
AIDS
Cardiovascular Disease

Interventions: Behavioral: Let's Move Program
Behavioral: Let's Flex Program
Behavioral: Group Motivational Interviewing

First Posted Date: 2016-03-17

Last Posted Date: 2023-07-06

Lead Sponsor: Emory University

Target Recruit Count: 115

Registration Number: NCT02711878

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Ponce De Leon Center, Atlanta, Georgia, United States

Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia

Phase 2

Terminated

Conditions: Leukemia
Chronic Myeloid Leukemia
Chronic Myelogenous Leukemia

Interventions: Drug: Dasatinib
Drug: Imatinib Mesylate
Drug: Nilotinib

First Posted Date: 2016-03-15

Last Posted Date: 2018-11-02

Lead Sponsor: Emory University

Target Recruit Count: 7

Registration Number: NCT02709083

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

The Effect of Dopamine on Diabetic Retinopathy

Phase 1

Completed

Conditions: Diabetes

Interventions: Drug: Low Dose Sinemet CR
Drug: High Dose Sinemet CR
Device: RETeval Electroretinogram (ERG) Testing
Other: Contrast Sensitivity Testing
Other: Visual Acuity Testing

First Posted Date: 2016-03-11

Last Posted Date: 2019-10-09

Lead Sponsor: Emory University

Target Recruit Count: 60

Registration Number: NCT02706977

Locations: 🇺🇸
Atlanta VA Medical Center, Atlanta, Georgia, United States

Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke

Not Applicable

Completed

Conditions: Stroke

Interventions: Behavioral: CARE-CITE Education Program
Behavioral: Traditional Education
Behavioral: Constraint-Induced Movement Therapy (CIMT)

First Posted Date: 2016-03-09

Last Posted Date: 2020-01-28

Lead Sponsor: Emory University

Target Recruit Count: 64

Registration Number: NCT02703532

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

Phase 2

Completed

Conditions: Recurrent Small Cell Lung Carcinoma

Interventions: Biological: Durvalumab
Radiation: Hypofractionated Radiation Therapy
Biological: Tremelimumab
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2016-03-08

Last Posted Date: 2021-06-22

Lead Sponsor: Emory University

Target Recruit Count: 18

Registration Number: NCT02701400

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients

Not Applicable

Completed

Conditions: Suicide, Suicidal Ideation

Interventions: Behavioral: Relief Link Application Daily Tasks

First Posted Date: 2016-02-25

Last Posted Date: 2017-12-15

Lead Sponsor: Emory University

Target Recruit Count: 13

Registration Number: NCT02691221

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States

Glucose Measurement Using Microneedle Patches

Not Applicable

Completed

Conditions: Diabetes

Interventions: Device: Microneedle patch
Device: Intravenous (IV) catheter
Device: Lancet

First Posted Date: 2016-02-15

Last Posted Date: 2020-01-03

Lead Sponsor: Emory University

Target Recruit Count: 15

Registration Number: NCT02682056

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory Children's Center, Atlanta, Georgia, United States

Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia

Phase 1

Withdrawn

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Dasatinib
Drug: Fludarabine
Drug: Cytarabine
Drug: Idarubicin
Drug: Intrathecal (IT) cytarabine

First Posted Date: 2016-02-12

Last Posted Date: 2018-04-19

Lead Sponsor: Emory University

Registration Number: NCT02680951

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy